F18-FDG-PET/CT thyroid incidentalomas: A wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value

Endocrine

Volumn 43, Issue 3, 2013, Pages 678-685

  Bertagna, Francesco ^a   Treglia, Giorgio ^b   Piccardo, Arnoldo ^c   Giovannini, Elisabetta ^b   Bosio, Giovanni ^a   Biasiotto, Giorgio ^a   Bahij, El Khayat ^a   Maroldi, Roberto ^a   Giubbini, Raffaele ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c GALLIERA HOSPITAL   (Italy)

Author keywords

F18 FDG; Incidentaloma; PET CT; Thyroid

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOCAL INCIDENTAL THYROID UPTAKE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HURTLE CELL CARCINOMA; INCIDENTAL FINDING; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; POORLY DIFFERENTIATED THYROID CANCER; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE CUT OFF; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID GLAND EXAMINATION; THYROID INCIDENTALOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR LOCALIZATION;

EID: 84877876018     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9837-2     Document Type: Article

References (48)

1. B. Burguera, H. Gharib, Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol. Metab. Clin. N. Am. 29, 187-203 (2000)
2. N.G. Iyer, A.R. Shaha, C.E. Silver, K.O. Devaney, A. Rinaldo, P.K. Pellitteri, A. Ferlito, Thyroid incidentalomas: to treat or not to treat. Eur. Arch. Otorhinolaryngol. 267, 1019-1026 (2010)
3. M. Salvatori, L. Melis, P. Castaldi, M.L. Maussier, V. Rufini, G. Perotti, D. Rubello, Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed. Pharmacother. 61, 488-493 (2007)
4. C. Are, J.F. Hsu, H. Schoder, J.P. Shah, S.M. Larson, A.R. Shaha, FDG-PET detected thyroid incidentalomas: need for further investigation? Ann. Surg. Oncol. 14, 239-247 (2007)
5. C. Are, J.F. Hsu, R.A. Chossein, H. Schoder, J.P. Shah, A.R. Shaha, Histological aggressiveness of fluoro deoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann. Surg. Oncol. 14, 3210-3215 (2007)
6. M.S. Cohen, N. Arslan, F. Dehdashti, G.M. Doherty, T.C. Lairmore, L.M. Brunt, J.F. Moley, Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130, 941-946 (2001)
7. Y.K. Chen, H.J. Ding, K.T. Chen, Y.L. Chen, A.C. Liao, Y.Y. Shen, C.T. Su, C.H. Kao, Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res. 25, 1421-1426 (2005)
8. J.Y. Choi, K.S. Lee, H.J. Kim, Y.M. Shim, O.J. Kwon, K. Park, C.H. Baek, J.H. Chung, K.H. Lee, B.T. Kim, Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J. Nucl. Med. 47, 609-615 (2006)
9. T.Y. Kim, W.B. Kim, J.S. Ryu, G. Gong, S.J. Hong, Y.K. Shong, 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115, 1074-1078 (2005)
10. T.V. Bogsrud, D. Karantanis, M.A. Nathan, B.P. Mullan, G.A. Wiseman, D.A. Collins, J.L. Kasperbauer, S.E. Strome, C.C. Reading, I.D. Hay, V.J. Lowe, The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl. Med. Commun. 28, 373-381 (2007)
11. Q.D. Chu, M.S. Connor, D.L. Lilien, L.W. Johnson, R.H. Turnage, B.D. Li, Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am. Surg. 72, 272-275 (2006)
12. H. Nishimori, R. Tabah, M. Hickeson, J. How, Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can. J. Surg. 54, 83-88 (2011)
13. T. Ishimori, P.V. Patel, R.L. Wahl, Detection of unexpected additional primary malignancies with PET/CT. J. Nucl. Med. 46, 752-757 (2005)
14. K.W. Kang, S.K. Kim, H.S. Kang, E.S. Lee, J.S. Sim, I.G. Lee, S.Y. Jeong, S.W. Kim, Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-xuorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J. Clin. Endocrinol. Metab. 88, 4100-4104 (2003)
15. I.L. Nilsson, F. Arnberg, J. Zedenius, A. Sundin, Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World J. Surg. 35, 2691-2697 (2011)
16. T.Y. Ho, M.J. Liou, K.J. Lin, T.C. Yen, Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40, 297-302 (2011)
17. B.H. Kim, M.A. Na, I.J. Kim, S.J. Kim, Y.K. Kim, Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann. Nucl. Med. 24, 721-728 (2010)
18. L. Pagano, M.T. Samà, F. Morani, F. Prodam, M. Rudoni, R. Boldorini, G. Valente, P. Marzullo, R. Baldelli, M. Appetecchia, C. Isidoro, G. Aimaretti, Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin. Endocrinol. 75, 528-534 (2011)
19. J.S. Bae, B.J. Chae, W.C. Park, J.S. Kim, S.H. Kim, S.S. Jung, B.J. Song, Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J. Surg. Oncol. 7, 63 (2009)
20. G. Zhai, M. Zhang, H. Xu, C. Zhu, B. Li, The role of 18F- fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. J. Endocrinol. Invest. 33, 151-155 (2010)
21. D.L. King, B.C. Stack Jr, P.M. Spring, R. Walker, D.L. Bodenner, Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol. Head Neck Surg. 137, 400-404 (2007)
22. S.Y. Nam, J.L. Roh, J.S. Kim, J.H. Lee, S.H. Choi, S.Y. Kim, Focal uptake of (18)Ffluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin. Endocrinol. 67, 135-139 (2007)
23. E. Even-Sapir, H. Lerman, M. Gutman, G. Lievshitz, L. Zuriel, A. Polliack, M. Inbar, U. Metser, The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur. J. Nucl. Med. Mol. Imaging 33, 541-552 (2006)
24. K. Ohba, S. Nishizawa, A. Matsushita, M. Inubushi, K. Nagayama, H. Iwaki, H. Matsunaga, S. Suzuki, S. Sasaki, Y. Oki, H. Okada, H. Nakamura, High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr. J. 57, 395-401 (2010)
25. J.Y. Kwak, E.K. Kim, M. Yun, A. Cho, M.J. Kim, E.J. Son, K.K. Oh, Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. AJR Am. J. Roentgenol. 191, 598-603 (2008)
26. H. Hsieh, S. Lin, B. Yang, Y. Chu, C. Chang, R. Liu, The clinical relevance of thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. Ann. Nucl. Med. Sci. 16, 53-58 (2003)
27. W. Chen, M. Parsons, D.A. Torigian, H. Zhuang, A. Alavi, Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl. Med. Commun. 30, 240-244 (2009)
28. J.A. Eloy, E.M. Brett, G.M. Fatterpekar, L. Kostakoglu, P.M. Som, S.C. Desai, E.M. Genden, The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am. J. Neuroradiol. 30, 1431-1434 (2009)
29. B.J. Kang, J.H. O, J.H. Baik, S.L. Jung, Y.H. Park, S.K. Chung, Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann. Nucl. Med. 23, 729-737 (2009)
30. S. Bonabi, F. Schmidt, M.A. Broglie, S.R. Haile, S.J. Stoeckli, Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur. Arch. Otorhinolaryngol. (2012). doi: 10.1007/s00405-012-1941-7
31. M.H. Pampaloni, A.Z. Win, Prevalence and characteristics of incidentalomas discovered by whole body FDG PETCT. Int. J. Mol. Imaging (2012). doi: 10.1155/2012/476763
32. W.M. Lee, B.J. Kim, M.H. Kim, S.C. Choi, S.Y. Ryu, I. Lim, K. Kim, Characteristics of thyroid incidentalomas detected by pre-treatment [F]FDG PET or PET/CT in patients with cervical cancer. J. Gynecol. Oncol. 23, 43-47 (2012)
33. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, S.I. Sherman, R.M. Tuttle, American thyroid association guidelines taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 16, 109-142 (2006)
34. R.S. Prichard, M. Cotter, D. Evoy, D. Gibbons, C. Collins, E. McDermott, S. Skehan, Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation. Ir. Med. J. 104, 177-179 (2011)
35. G. Treglia, L. Giovanella, F. Bertagna, D. Di Franco, M. Salvatori, A pooled analysis to calculate the prevalence and risk of malignancy of thyroid incidentalomas detected by fluorine-18-fluorodeoxyglucose positron emission tomography. Thyroid. (2012). doi: 10.1089/thy.2012-0216
36. F. Bertagna, G. Treglia, A. Piccardo, R. Giubbini, Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J. Clin. Endocrinol. Metab. (2012). doi: 10.1210/jc.2012-2390
37. F. Pacini, Changing natural history of differentiated thyroid cancer. Endocrine 42, 229-230 (2012)
38. L. Pagano, M. Caputo, M.T. Samà, V. Garbaccio, M. Zavattaro, M.G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti, Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine 42, 382-390 (2012)
39. S. Kauhanen, C. Schalin-Jäntti, Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer? Endocrine (2012). doi: 10.1007/s12020-012-9740-x
40. G. Treglia, A. Del Ciello, D. Di Franco, Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT. Endocrine (2012). doi: 10.1007/s12020-012-9782-0
41. G. Fadda, F. Basolo, A. Bondi, G. Bussolati, A. Crescenzi, O. Nappi, F. Nardi, M. Papotti, G. Taddei, L. Palombini, SIAPEC-IAP Italian Consensus Working Group. Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 102, 405-408 (2010)
42. U. Feine, R. Lietzenmayer, J.P. Hanke, J. Held, H. Wöhrle, W. Müller-Schauenburg, Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J. Nucl. Med. 37, 1468-1472 (1996)
43. F. Grabellus, J. Nagarajah, A. Bockisch, S. Kurt Werner, S.Y. Sheu, Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin. Nucl. Med. 37, 121-127 (2012)
44. F. Morani, L. Pagano, F. Prodam, G. Aimaretti, C. Isidoro, Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression. Panminerva Med. 54, 59-63 (2012)
45. A.L. Traugott, F. Dehdashti, K. Trinkaus, M. Cohen, E. Fialkowski, F. Quayle, H. Hussain, R. Davila, L. Ylagan, J.F. Moley, Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J. Surg. 34, 1247-1253 (2010)
46. A.D. Bloom, L.P. Adler, J.M. Shuck, Determination of malignancy of thyroid nodules with positron emission tomography. Surgery. 114, 728-734; discussion 734-735 (1993)
47. J.C. Mitchell, F. Grant, A.R. Evenson, J.A. Parker, P.O. Hasselgren, S. Parangi, Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery. 138, 1166-1174; discussion 1174-1175 (2005)
48. J.M. Kim, J.S. Ryu, T.Y. Kim, W.B. Kim, G.Y. Kwon, G. Gong, D.H. Moon, S.C. Kim, S.J. Hong, Y.K. Shong, 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J. Clin. Endocrinol. Metab. 92, 1630-1634 (2007)